Corporate Sponsored Funding

January 19, 2021

PIVOT Center works with companies to thoroughly understand their R&D goals and match them to research goals of the appropriate faculty members at the University of Utah. PIVOT’s Corporate Engagement team works across all schools and units to facilitate partnerships and offer expertise on identifying opportunities that include grant funding, sponsored research and creating strategic corporate partnerships. PIVOT also provides guidance to faculty for successful stewardship. Please contact Sadhna Kohli (Director of Corporate Engagement) for more information regarding these opportunities, or if you have any questions.

Clinical Investigator Award
Sponsor: Society of Surgical Oncology
Amount: $100,000
Deadline: January 21^st, 2021

The goal of the Clinical Investigator Award (CIA) program is to promote patient-oriented research through the training of surgical oncologists in clinical and translational science. Applicants must be surgical oncologists within 8 years of completion of training and be full SSO members for at least 6 months prior to application submission to be eligible for the award.

Click here to learn more!

Pfizer: 2021 Rheumatology Competitive Grant Program
Amount: $150,000
Deadline: January 22^nd, 2021

The intent of this Request for Proposal (RFP) is to support both clinical and basic science research on the pathogenesis and treatment of Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and/or Ankylosing Spondylarthrosis (AS) with a specific focus on projects that are most relevant to improving patient care.

All US investigators are encouraged to apply, including young investigators who are in the early stages of their career.

Click here to learn more!

Pfizer and Astellas: Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
Amount: $200,000
Deadline: January 28, 2021

The purpose of this CGA is to encourage Organizations to submit grant applications for independent CME/CE certified education designed to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer

Click here to learn more!

Pfizer and GE Healthcare: 2020 RD US- Next Generation PET Imaging for ATTR-CM
Amount: $125,000
Deadline: February 1^st, 2021

Through this Research RFP, Pfizer and GE Healthcare wish to support research projects focused on assessing both diagnostic performance and changes over time of 18F-flutemetamol cardiac uptake after initiation of Tafamidis treatment in subjects diagnosed with ATTR cardiac amyloidosis.

Click here to learn more!

Motorola Solutions Foundation: 2021 Grant Program
Amount: $50,000
Deadline: Inquiry forms due February 1^st, 2021

The Motorola Solutions Foundation acts as the charitable and philanthropic arm of Motorola Solutions and focuses on giving back to the community through strategic grants, employee volunteerism and other community investment initiatives. The Foundation is one of the many ways in which the company lives out its purpose to help people be their best in the moments that matter.

Click here to learn more!

Pfizer: 2021 Ulcerative Colitis Competitive Grant Program
Amount: $75,000 to $150,000
Deadline: February 16^th, 2021

The intent of this Request for Proposal (RFP) is to support both clinical and basic science research on the pathogenesis and treatment of Ulcerative Colitis (UC) with a specific focus on projects that are most relevant to improving patient care.

Click here to learn more!

Pfizer: Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant Lipoproteins
Amount: $100,000 to $150,000
Deadline: February 18^th, 2021

Through this RFP, the intention is to support educational programs focused on understanding residual cardiovascular (CV) risk associated with triglyceride (TG)-rich remnant lipoproteins

Click here to learn more!

Ono Pharma Breakthrough Science Initiative Awards Program
Amount: $900,000 for three years, and additional institutional indirect costs up to 15%.
Deadline: February 18, 2021, 5pm ET

Proposals from Principal Investigators will be considered for high-risk and high-reward science research projects which have potential to lead to science discoveries/solutions and, based on further research, to breakthrough treatments for patients. Applications will be considered from Principal Investigators in the Chemical Biology field for laboratory investigation to be carried out in the United States and Canada.

Click here to learn more!

Pfizer: Inflammatory and Immune-Mediated Dermatologic Disorders
Amount: $175,000
Deadline: February 24^th, 2021

Click here to learn more!

Pfizer: 2021 Global Hemophilia ASPIRE
Amount: $70,000 to $90,000
Deadline: March 1^st, 2021

Projects that will be considered for Pfizer support will focus on the following areas:

Basic and Clinical Science of Gene Therapy for Hemophilia
Basic and Clinical Science of Tissue Factor Pathway Inhibitor (TFPI) and anti-TFPI monoclonal
Burden of disease: Clinical Hemophilia A and B

Note: Pfizer will not supply any study drug

Click here to learn more!

Comcast: Innovation Fund
Amount: $150,000
Deadline: Rolling submissions starting January 1^st, 2021 until funds are exhausted

Covid-19 effects on the Internet is a special focus area of interest for the 2021 funding year. Other areas of interest include proposals related to Network and User Security; All things Video, including Caching, Streaming, Transport, Encoding, Distribution and Production; Content Delivery Networks; DNS Operations and Management; Encrypted DNS; Broadband; Routing; Home Security; Network Optimization and Measurement; Faster Wifi, etc.

Click here to learn more!

Categories

Featured Posts

Blog Archive

Tag Cloud